Data_Sheet_1_Specnuezhenide Decreases Interleukin-1β-Induced Inflammation in Rat Chondrocytes and Reduces Joint Destruction in Osteoarthritic Rats.DOCX
As a chronic disease, osteoarthritis (OA) leads to the degradation of both cartilage and subchondral bone, its development being mediated by proinflammatory cytokines like interleukin-1β. In the present study, the anti-inflammatory effect of specnuezhenide (SPN) in OA and its underlying mechanism were studied in vitro and in vivo. The results showed that SPN decreases the expression of cartilage matrix-degrading enzymes and the activation of NF-κB and wnt/β-catenin signaling, and increases chondrocyte-specific gene expression in IL-1β-induced inflammation in chondrocytes. Furthermore, SPN treatment prevents the degeneration of both cartilage and subchondral bone in a rat model of OA. To the best of our knowledge, this study is the first to report that SPN decreases interleukin-1β-induced inflammation in rat chondrocytes by inhibiting the activation of the NF-κB and wnt/β-catenin pathways, and, thus, has therapeutic potential in the treatment of OA.
History
References
- https://doi.org//10.1101/gad.230302
- https://doi.org//10.1136/ard.2004.025270
- https://doi.org//10.1016/j.joca.2009.08.010
- https://doi.org//10.3390/ijms18010133
- https://doi.org//10.1002/art.10627
- https://doi.org//10.1016/j.cell.2012.05.012
- https://doi.org//10.1055/s-0029-1240869
- https://doi.org//10.1359/jbmr.081115
- https://doi.org//10.1186/ar4405
- https://doi.org//10.1016/j.jsbmb.2012.10.001
- https://doi.org//10.1016/S0092-8674(02)00685-2
- https://doi.org//10.1038/nrrheum.2014.162
- https://doi.org//10.1002/art.21813
- https://doi.org//10.1002/art.21373
- https://doi.org//10.3389/fimmu.2016.00378
- https://doi.org//10.1002/art.34425
- https://doi.org//10.1016/j.devcel.2009.06.016
- https://doi.org//10.2174/138945010791011938
- https://doi.org//10.1002/art.10331
- https://doi.org//10.1016/j.joca.2010.11.006
- https://doi.org//10.1136/rmdopen-2015-000061
- https://doi.org//10.1038/sj.onc.1209937
- https://doi.org//10.1016/j.joca.2005.07.014
- https://doi.org//10.1016/j.joca.2006.04.008
- https://doi.org//10.1136/ard.2004.022434
- https://doi.org//10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C
- https://doi.org//10.1016/j.bbapap.2011.06.020
- https://doi.org//10.3390/molecules21121756
- https://doi.org//10.1016/j.joca.2015.06.014
- https://doi.org//10.1038/nm.3143
- https://doi.org//10.1155/2013/809579
CC BY 4.0